Since the 1970s, Australian health professionals have had access to Therapeutic Guidelines that provide clear, evidence-based recommendations for patient therapy that are totally independent of both the pharmaceutical industry and government. Health professionals working in developing countries are not so fortunate. They do not usually have access to any independent therapeutic information about which medicines to use to achieve the best health outcome for their patients. In this absence, much of their information is supplied by a willing pharmaceutical industry wanting to maximise sales of their products.

Even though Therapeutic Guidelines are developed for the Australian health care system, most of the information is valid in other countries and over the years TGL has responded to hundreds of requests for its books and electronic products from health workers in developing countries. TGL has always been committed to providing complimentary books and subscriptions to these health workers.

In 2007, TGL established a Visiting Editor Fellowship program, which provided individually tailored editorial training to one health professional from a developing country each year. To date, TGL has hosted Visiting Editors from India, Cuba, Tonga, Palau, the Philippines, Kiribati and Nigeria.

In August 2013, TGL established Therapeutic Guidelines Foundation to support the creation and distribution of independent therapeutic information to developing countries and help promote the quality use of medicines and other therapies.

The Foundation’s highest priority is to support the Developing Countries Program that TGL established and enable its expansion into other activities, such as the development of locally adapted guidelines, and the delivery of locally-based education and training programs.

If you would like to support the work of the Foundation – Go to the Therapeutic Guidelines Foundation website.

To discuss complimentary access to Therapeutic Guidelines or to learn about how the Developing Countries Program may be able to support local guideline development, the visiting editor fellowship program and other activities to promote quality use of medicines please email the program manager at